Hong Kong Retail IPO Demand Splits: Neautus 2,191 Times Covered, Denglin Just 2.11 Times
Two small November listings drew 82% of retail applications across seven deals, and margin tallies show Sinotau's book heading the same way before it closes on Thursday.

What to know
- Neautus and RelyEZ drew 119,530 of the 145,656 valid retail applications filed for the seven Hong Kong IPOs that listed from Nov. 9 to Nov. 13, about 82%.
- Neautus's retail tranche was 2,190.99 times subscribed and RelyEZ's 1,388.75 times, while Denglin's was 2.11 times and Hosin's 2.37 times, allotment filings show.
- The SFC expects brokers to collect upfront deposits of at least 10% on IPO orders that clients do not fully fund, a standard set in a March 2025 circular.
HONG KONG
Hong Kong's retail investors are piling into a handful of small new listings and largely sitting out the big ones. Of the 145,656 valid public applications filed for the seven initial public offerings that began trading between Nov. 9 and Nov. 13, Chinese medicine maker Sichuan Neautus and energy storage firm RelyEZ drew 119,530, or about 82%, according to the companies' allotment filings.
The split matters for anyone who subscribes to new issues through a broker, especially with borrowed money. The two most crowded deals were the two smallest by money raised, so the odds of getting shares were slim, and the largest single orders ran to tens of millions of Hong Kong dollars. Margin tallies for Beijing Sinotau, whose retail offer closes at noon on Thursday, suggest the pattern is repeating.
Seven deals, two crowds
Neautus's retail tranche was 2,190.99 times subscribed, with 58,843 valid applications, while its international book was covered 1.25 times. RelyEZ's retail portion was 1,388.75 times subscribed from 60,687 applications, against 1.30 times for institutions. They were the two smallest of the seven offerings: Neautus raised HK$262 million and RelyEZ HK$562.7 million.
The larger technology deals saw far thinner public demand. GPU designer Suzhou Denglin Technology raised HK$1.41 billion, yet its retail tranche was only 2.11 times subscribed, from 3,809 applications, and every applicant received shares. HOSIN Electronics drew 4,625 applications for a book covered 2.37 times. Jiangsu Xinde Semiconductor (9.84 times), Amicro Technology (13.95 times) and satellite maker ADASPACE (3.43 times) fell in between.
First-day trading rewarded the crowded books. RelyEZ traded at HK$22.40 on its Nov. 9 debut, 129% above its HK$9.78 offer price, The Standard reported. Neautus closed its first session 71.6% higher. Denglin opened 0.9% below its HK$231 offer price, while Xinde opened 20.5% higher, the paper reported. Capital Times has tracked how recent listings have traded against their offer prices.
Heavy demand did not mean more shares for the public. In both the Neautus and RelyEZ filings, the retail slice stayed at 10% of the deal, with no shares reallocated from the institutional book.
What a 2,000-times book means for an applicant
The ballot tables in the filings show how little a typical applicant received. At Neautus, 8,915 people applied for a single 50-share board lot, worth HK$2,010 at the offer price; 179 of them, or about 2%, got it. At the top of the table, 1,167 applicants each sought 325,850 shares, an order worth about HK$13.1 million before fees. Each received one 50-share lot, and 306 of them were drawn for a second.
RelyEZ was similar. Of the 20,144 applicants for one 500-share lot, 1,008 were successful, about 5%. The 507 largest applicants, each asking for 2,877,000 shares worth about HK$28.1 million at the offer price, all received one lot of 500 shares, and 38 of them got a second.
Brokers can lend clients part of the cost of an IPO order, and the Securities and Futures Commission tightened its expectations for that lending in March 2025. Its circular says that when a client does not fully pre-fund an IPO order, the broker is expected to collect an upfront deposit of at least 10% of the subscription amount. The regulator issued the guidance after a review found some brokers had engaged in "imprudent and aggressive IPO financing practices," it said at the time. Bloomberg, in a report carried by China Daily Hong Kong, said some broker IPO loans had been offered at interest rates as low as 0%.
Under that standard, the largest RelyEZ order would have required a deposit of at least about HK$2.8 million to secure what turned out to be 500 shares, worth HK$4,890 at the offer price. Margin interest is charged on the full borrowed amount for the days the money is locked up, so the rate and the number of days matter as much as the allotment.
Sinotau's book fills before Thursday close
Beijing Sinotau, a radiopharmaceutical developer, is offering 656,100 H shares to the public, 10% of its deal, at HK$52 to HK$68 each, according to its formal notice. Its offer structure allows the retail portion to rise to at most 984,150 shares, about 15% of the shares initially offered. A 50-share lot costs HK$3,434.29 including fees at the top of the range.
Demand built quickly. The retail tranche was 51 times oversubscribed by 10 p.m. on Monday, the first day of the offer, Oriental Daily News reported. By Tuesday, broker margin tallies showed the book more than 256 times covered, according to Guandian, while Zhitong Finance put it at 277.84 times, citing lending by brokers including Futu Securities and Phillip Securities. Those figures count broker financing pledged during the offer period and can differ from the final subscription level in the allotment notice.
Sinotau is also the first Hong Kong IPO to be issued in uncertificated form, Oriental Daily reported. Its notice says no physical share certificates will be issued. Investors who hold through banks or brokers are not affected by the change, The Standard reported, citing the SFC.
The company expects to set its price by noon on Friday, Nov. 20, and to publish allotment results, including the final subscription level and the ballot table, by Monday, Nov. 23. Trading is scheduled to start on Tuesday, Nov. 24, under stock code 9941. For background on this year's listing boom, see Capital Times' report on Hong Kong's record fundraising pace.
Sources
- HKEXnews: RelyEZ Energy Storage: Announcement of Final Offer Price and Allotment Results (Nov. 6, 2026)
- HKEXnews: Sichuan Neautus Traditional Chinese Medicine: Announcement of Final Offer Price and Allotment Results (Nov. 10, 2026)
- HKEXnews: Suzhou Denglin Technology: Announcement of Final Offer Price and Allotment Results (Nov. 9, 2026)
- HKEXnews: Jiangsu Xinde Semiconductor Technology: Announcement of Final Offer Price and Allotment Results (Nov. 9, 2026)
- HKEXnews: HOSIN Electronics: Announcement of Final Offer Price and Allotment Results (Nov. 11, 2026)
- HKEXnews: Amicro Technology: Announcement of Final Offer Price and Allotment Results (Nov. 11, 2026)
- HKEXnews: ADASPACE: Announcement of Final Offer Price and Allotment Results (Nov. 12, 2026)
- The Standard: Chinese energy storage firm RelyEZ jumps on Hong Kong debut (Nov. 9, 2026)
- The Standard: Chinese traditional medicine firm Neautus ends 72 percent higher in Hong Kong debut (Nov. 11, 2026)
- The Standard: Chinese chip firms Denglin, Xinde open mixed in Hong Kong debuts (Nov. 10, 2026)
- HKEXnews: Beijing Sinotau International Pharmaceutical Technology: Global Offering (formal notice) (Nov. 16, 2026)
- Oriental Daily News: 先通醫藥招股 3434元入場 (Nov. 17, 2026)
- Guandian (via Sohu): 先通医药招股次日孖展超购逾256倍 (Nov. 17, 2026)
- Zhitong Finance (via Sohu): 新股孖展统计 (Nov. 17, 2026)
- Securities and Futures Commission: Circular to licensed corporations on IPO subscription and financing services (March 20, 2025)
- Securities and Futures Commission: SFC issues additional guidance on IPO subscription and financing services (March 20, 2025)
- China Daily Hong Kong (Bloomberg): Hong Kong caps IPO margin loans amid heated retail demand (March 20, 2025)
- The Standard: 2,200 sign up for USI account after uncertificated securities market rollout: Computershare (Nov. 17, 2026)
Our standards: Capital Times reports under the principles set out in our Editorial Standards and Ethics Policy. Spotted an error? Report it to our editors.







